Abstract
Purpose
This study aimed at reviewing our experience with infections caused by Fusobacterium in children.
Methods
A retrospective analysis of medical records of children admitted to Hadassah-Hebrew University Medical Center from 2000 to 2013, in whom Fusobacterium spp. was identified in any specimen.
Results
A total of 22 patients (males = 12) at a mean ± SE age of 5 ± 1 (range 1–17) years, were identified. The most common complication was abscess formation (n = 11, 50 %). Eight children (36.4 %) had intracranial complications, including brain abscess (n = 4), meningitis (n = 4) and cerebral sinus vein thrombosis (CSVT, n = 5). Seventeen children (77 %) had bacteremia. Primary site of infection was otogenic (n = 9), oropharyngeal (n = 7), respiratory (n = 2), sinuses (n = 2), intra-abdominal (n = 1) and mucositis (n = 1). Fourteen cases were caused by Fusobacterium necrophorum, including four cases with CSVT, 7/8 cases of mastoiditis, four of them with subperiosteal abscess formation; all four cases with meningitis and two brain abscesses. Fifteen (68 %) patients required surgical intervention and 3 (14 %) received anti-coagulation therapy. Excluding one patient with overwhelming sepsis with fatal outcome, all patients recovered.
Conclusions
Fusobacterium infections in children can cause a diverse spectrum of disease and is associated with high rates of abscess formation and intracranial complications. Although Fusobacterium nucleatum is abundant in the oral cavity, F. necrophorum is the main pathogen that causes severe infections in healthy children.
Similar content being viewed by others
References
Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev. 2007;20:622–59. doi:10.1128/CMR.00011-07.
Pett E, Saeed K, Dryden M. Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infect. 2013;. doi:10.1007/s15010-013-0564-2.
Goldberg EA, Venkat-Ramani T, Hewit M, Bonilla HF. Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia. Epidemiol Infect. 2013;141:325–9. doi:10.1017/S0950268812000660.
Brook I. Fusobacterial infections in children. J Infect. 1994;28:155–65.
Huggan PJ, Murdoch DR. Fusobacterial infections: clinical spectrum and incidence of invasive disease. J Infect. 2008;57:283–9. doi:10.1016/j.jinf.2008.07.016.
Nohrström E, Mattila T, Pettilä V, Kuusela P, Carlson P, Kentala E, et al. Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia. Scand J Infect Dis. 2011;43:463–70. doi:10.3109/00365548.2011.565071.
Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet. 1936;1:701–3.
Bailhache M, Mariani-Kurkdjian P, Lehours P, Sarlangue J, Pillet P, Bingen E, et al. Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres. Eur J Clin Microbiol Infect Dis. 2013;32:1041–7. doi:10.1007/s10096-013-1848-2.
Le Monnier A, Jamet A, Carbonnelle E, Barthod G, Moumile K, Lesage F, et al. Fusobacterium necrophorum middle ear infections in children and related complications: report of 25 cases and literature review. Pediatr Infect Dis J. 2008;27:613–7. doi:10.1097/INF.0b013e318169035e.
Righini CA, Karkas A, Tourniaire R, N’Gouan JM, Schmerber S, Reyt E, et al. Lemierre syndrome: study of 11 cases and literature review. Head Neck. 2014;36:1044–51. doi:10.1002/hed.23410.
Megged O, Assous MV, Miskin H, Peleg U, Schlesinger Y. Neurologic manifestations of Fusobacterium infections in children. Eur J Pediatr. 2013;172:77–83. doi:10.1007/s00431-012-1847-9.
Sama Ashan JN. Age-specific leukocyte differential. In: Megan M, Tschudy KMA, editors. The Johns Hopkins Hospital : the Harriet Lane Handbook, vol. 19. Philadelphia: Elesvier; 2012. p. 333.
Arcara KM. Blood chemistries and body fluids. The Johns Hopkins Hospital : the Harriet Lane Handbook, vol. 19. Philadelphia: Elesvier; 2012. p. 648.
Brook I, Hunter V, Walker RI. Synergistic effect of bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice. J Infect Dis. 1984;149:924–8.
Yarden-Bilavsky H, Raveh E, Livni G, Scheuerman O, Amir J, Bilavsky E. Fusobacterium necrophorum mastoiditis in children—emerging pathogen in an old disease. Int J Pediatr Otorhinolaryngol. 2013;77:92–6. doi:10.1016/j.ijporl.2012.10.003.
Klug TE, Rusan M, Fuursted K, Ovesen T. Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis. 2009;49:1467–72. doi:10.1086/644616.
Gedik AH, Cakir E, Soysal O, Umutoğlu T. Endobronchial lesion due to pulmonary Fusobacterium nucleatum infection in a child. Pediatr Pulmonol. 2014;49:E63–5. doi:10.1002/ppul.22834.
Veldhoen ES, Wolfs TF, van Vught AJ. Two cases of fatal meningitis due to Fusobacterium necrophorum. Pediatr Neurol. 2007;36:261–3. doi:S0887-8994(06)00676-X [pii] 10.1016/j.pediatrneurol.2006.11.005.
Zhong D, Brower-Sinning R, Firek B, Morowitz MJ. Acute appendicitis in children is associated with an abundance of bacteria from the phylum Fusobacteria. J Pediatr Surg. 2014;49:441–6. doi:10.1016/j.jpedsurg.2013.06.026.
Kroon E, Arents NA, Halbertsma FJ. Septic arthritis and osteomyelitis in a 10-year-old boy, caused by Fusobacterium nucleatum, diagnosed with PCR/16S ribosomal bacterial DNA amplification. BMJ Case Rep. 2012;. doi:10.1136/bcr.12.2011.5335.
Ramos A, Berbari E, Huddleston P. Diagnosis and treatment of Fusobacterium nucleatum discitis and vertebral osteomyelitis: case report and review of the literature. Spine. 2013;38:E120–2. doi:10.1097/BRS.0b013e31827b4d61 (Phila Pa 1976).
Domann E, Hong G, Imirzalioglu C, Turschner S, Kühle J, Watzel C, et al. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J Clin Microbiol. 2003;41:5500–10.
Batty A, Wren MW, Gal M. Fusobacterium necrophorum as the cause of recurrent sore throat: comparison of isolates from persistent sore throat syndrome and Lemierre’s disease. J Infect. 2005;51:299–306. doi:10.1016/j.jinf.2004.09.013.
Fatakhov E, Patel MK, Santha S, Koch CF. Fusobacterium necrophorum: a rare cause of hepatic abscess in an immunocompetent individual. BMJ Case Rep. 2013;. doi:10.1136/bcr-2013-200748.
Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre’s syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012;12:808–15. doi:10.1016/S1473-3099(12)70089-0.
Ramirez S, Hild TG, Rudolph CN, Sty JR, Kehl SC, Havens P, et al. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a children’s hospital. Pediatr. 2003;112:e380.
Islam AK, Shneerson JM. Primary meningitis caused by Bacteroides fragilis and Fusobacterium necrophorum. Postgrad Med J. 1980;56:351–3.
Jones TH, Bergvall V, Bradshaw JP. Carotid artery stenoses and thrombosis secondary to cavernous sinus thromboses in Fusobacterium necrophorum meningitis. Postgrad Med J. 1990;66:747–50.
Bourgault AM, Lamothe F, Dolcé P, Saint-Jean L, Saint-Antoine P. Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis. 1997;25:S181–3.
Henry S, DeMaria A, McCabe WR. Bacteremia due to Fusobacterium species. Am J Med. 1983;75:225–31.
Kristensen LH, Prag J. Human necrobacillosis, with emphasis on Lemierre’s syndrome. Clin Infect Dis. 2000;31:524–32. doi:10.1086/313970.
Stokroos RJ, Manni JJ, de Kruijk JR, Soudijn ER. Lemierre syndrome and acute mastoiditis. Arch Otolaryngol Head Neck Surg. 1999;125:589–91.
Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141–7. doi:10.1016/j.mib.2014.11.013.
Creemers-Schild D, Gronthoud F, Spanjaard L, Visser LG, Brouwer CN, Kuijper EJ. Fusobacterium necrophorum, an emerging pathogen of otogenic and paranasal infections? New Microbes New Infect. 2014;2:52–7. doi:10.1002/nmi2.39.
Brook I, Wexler HM, Goldstein EJ. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev. 2013;26:526–46. doi:10.1128/CMR.00086-12.
Marchand-Austin A, Rawte P, Toye B, Jamieson FB, Farrell DJ, Patel SN. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010–2011. Anaerobe. 2014;28C:120–5. doi:10.1016/j.anaerobe.2014.05.015.
Phua CK, Chadachan VM, Acharya R. Lemierre syndrome-should we anticoagulate? A case report and review of the literature. Int J Angiol. 2013;22:137–42. doi:10.1055/s-0033-1336828.
Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e737S–801S. doi:10.1378/chest.11-2308.
Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6:595–603. doi:10.1016/S1474-4422(07)70131-X.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shamriz, O., Engelhard, D., Temper, V. et al. Infections caused by Fusobacterium in children: a 14-year single-center experience. Infection 43, 663–670 (2015). https://doi.org/10.1007/s15010-015-0782-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-015-0782-x